XONAR (Private limited company)

Fundament, Xonar Clinical Research
BE 0793.600.649 Active ●Vaatjesstraat 5, 2580 Putte

XONAR is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0793.600.649. It was founded on 15-11-2022. Its registered office is in Putte. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 51 733 and a loss of € 7 077. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0793.600.649
VAT registered
Yes
Founded
15-11-2022
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 3 of 3 years
Peppol e-invoicing
Registered
Registered office
Vaatjesstraat 5, 2580 Putte
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21100 Fabrication de produits pharmaceutiques de base
43990 Autres travaux de construction spécialisés nca
63100 Infrastructure informatique, traitement de données, hébergement et activités connexes
72109 Recherche-développement en autres sciences physiques et naturelles
73200 Études de marché et sondages
74999 Autres activités des professions libérales et autres activités scientifiques et techniques, nca
82100 Activités de service de bureau et de soutien administratif

Key figures of XONAR

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -7 077€ 24 028-29 %€ 33 783
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 51 733-12 %€ 58 811+69 %€ 34 783
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 143 913+18 %€ 122 334+95 %€ 62 734
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 14 120-63 %€ 37 765-21 %€ 47 702
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
---

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
Janssen Pharmaceutica 2340 Beerse
PFIZER MANUFACTURING BELGIUM 2870 Puurs-Sint-Amands
Organon Heist 2220 Heist-op-den-Berg
Kaneka Belgium 2260 Westerlo
DE CEUSTER MESTSTOFFEN 2280 Grobbendonk
CAPSUGEL BELGIUM 2880 Bornem
MEDICA 2550 Kontich
Novartis Manufacturing 2870 Puurs-Sint-Amands
Looking for more information about XONAR?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is XONAR still active? Yes. The Crossroads Bank for Enterprises lists XONAR as active.

What is the VAT number of XONAR? The VAT number of XONAR is BE 0793.600.649.

When was XONAR founded? XONAR was founded on 15-11-2022.

What is the address of XONAR? The current registered office of XONAR is Vaatjesstraat 5, 2580 Putte.

When did XONAR last file annual accounts? The latest annual accounts of XONAR were filed on 13-07-2026.

Does XONAR file its annual accounts on time? Yes. XONAR filed its annual accounts within the legal deadline for each of its last 3 financial years.

Is XONAR financially healthy? Addrly gives XONAR a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is XONAR profitable? The annual accounts of XONAR for 2025 show a loss of € 7 077.

What is the equity of XONAR? The equity of XONAR was € 51 733 at the close of the 2025 financial year.

Who are the directors of XONAR? The annual accounts of XONAR record 2 mandates. The names, roles and dates are visible with a free account.

Can XONAR receive Peppol e-invoices? Yes. XONAR is registered on the Peppol network and can receive structured electronic invoices.

What does XONAR do? The main activity of XONAR is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data